Last reviewed · How we verify
Sulfadiazine Toxicity
Approved treatments
- Wellcovorin · Pfizer Japan Inc
- Fusilev · Spectrum Pharms
- Fusilev · Acrotech Biopharma
Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Sulfadiazine Toxicity patent landscape — cliff calendar, originator estates, attackable patents
- Sulfadiazine Toxicity treatment landscape brief
- Sulfadiazine Toxicity treatment updates RSS
Frequently asked questions about Sulfadiazine Toxicity
What drugs treat Sulfadiazine Toxicity?
Tracked treatments include Wellcovorin, Fusilev.
What is the treatment for Sulfadiazine Toxicity?
Standard treatment for Sulfadiazine Toxicity includes Wellcovorin, Fusilev. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Sulfadiazine Toxicity patent cliff · Sulfadiazine Toxicity CI report
- Treatment: Wellcovorin · Pfizer Japan Inc
- Treatment: Fusilev · Spectrum Pharms
- Treatment: Fusilev · Acrotech Biopharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing